EGFR-TKI for Advanced NSCLC Market

EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutations.

EGFR-TKI for Advanced NSCLC Market contains market size and forecasts of EGFR-TKI for Advanced NSCLC in Global, including the following market information:

• Global EGFR-TKI for Advanced NSCLC Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global EGFR-TKI for Advanced NSCLC market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Gefitinib Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of EGFR-TKI for Advanced NSCLC include Henan DaKen Chemical, Capot Chemical Co.,Ltd., Chemwill Asia Co.,Ltd., MSN Labs, Sun Pharma, Amadis Chemical, Chongqing Chemdad Co., Ltd, Mylan and Alchem Pharmtech,Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the EGFR-TKI for Advanced NSCLC companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global EGFR-TKI for Advanced NSCLC Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global EGFR-TKI for Advanced NSCLC Market Segment Percentages, by Type, 2021 (%)

• Gefitinib
• Erlotinib
• Afatinib

Global EGFR-TKI for Advanced NSCLC Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global EGFR-TKI for Advanced NSCLC Market Segment Percentages, by Application, 2021 (%)

• Combination Therapy
• Mono Therapy

Global EGFR-TKI for Advanced NSCLC Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global EGFR-TKI for Advanced NSCLC Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies EGFR-TKI for Advanced NSCLC revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies EGFR-TKI for Advanced NSCLC revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Henan DaKen Chemical
• Capot Chemical Co.,Ltd.
• Chemwill Asia Co.,Ltd.
• MSN Labs
• Sun Pharma
• Amadis Chemical
• Chongqing Chemdad Co., Ltd
• Mylan
• Alchem Pharmtech,Inc.